Half-year report · HY
2689.TEDINET S100XKW2
Period2025-07-01 → 2025-12-31
Filed2026-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥62.4bn | 2025-07-01 → 2025-12-31 | Cons. | Net sales |
| Revenue | ¥122.7bn | 2024-07-01 → 2025-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥60.6bn | 2024-07-01 → 2024-12-31 | Cons. | Net sales |
| Operating income | ¥674m | 2025-07-01 → 2025-12-31 | Cons. | Operating income |
| Operating income | ¥808m | 2024-07-01 → 2024-12-31 | Cons. | Operating income |
| Ordinary income | ¥675m | 2025-07-01 → 2025-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.0bn | 2024-07-01 → 2025-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥824m | 2024-07-01 → 2024-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥695m | 2025-07-01 → 2025-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥816m | 2024-07-01 → 2024-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥451m | 2025-07-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.4bn | 2024-07-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥648m | 2024-07-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥451m | 2025-07-01 → 2025-12-31 | Cons. | Profit loss |
| Net income | ¥648m | 2024-07-01 → 2024-12-31 | Cons. | Profit loss |
| Total assets | ¥48.1bn | at 2025-12-31 | Cons. | Assets |
| Total assets | ¥45.9bn | at 2025-06-30 | Cons. | Assets |
| Total assets | ¥46.8bn | at 2024-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥36.0bn | at 2025-12-31 | Cons. | Liabilities |
| Total liabilities | ¥33.6bn | at 2025-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥12.2bn | at 2025-12-31 | Cons. | Net assets |
| Net assets / equity | ¥12.3bn | at 2025-06-30 | Cons. | Net assets |
| Net assets / equity | ¥11.5bn | at 2024-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.9bn | at 2025-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.5bn | at 2025-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.9bn | at 2025-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.4bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.6bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.7bn | at 2024-06-30v | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥772m | 2025-07-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.6bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥800m | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥977m | 2025-07-01 → 2025-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.6bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥889m | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥1.2bn | 2025-07-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥687m | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.5bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥76.02 | 2025-07-01 → 2025-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥241.43 | 2024-07-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥109.44 | 2024-07-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 25.3% | at 2025-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.7% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 24.6% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 38
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-07-01 → 2025-12-31 | −¥966m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-07-01 → 2025-12-31 | −¥966m |
| Reconciling Itemsreconciling | segment profit | 2025-07-01 → 2025-12-31 | −¥68m |
| Care Nursing Goodsreportable segment | revenue | 2025-07-01 → 2025-12-31 | ¥1.5bn |
| Care Nursing Goodsreportable segment | revenue external | 2025-07-01 → 2025-12-31 | ¥1.5bn |
| Care Nursing Goodsreportable segment | revenue intersegment | 2025-07-01 → 2025-12-31 | ¥114,000 |
| Care Nursing Goodsreportable segment | segment profit | 2025-07-01 → 2025-12-31 | ¥122m |
| Medical Equipmentreportable segment | revenue | 2025-07-01 → 2025-12-31 | ¥58.9bn |
| Medical Equipmentreportable segment | revenue external | 2025-07-01 → 2025-12-31 | ¥58.0bn |
| Medical Equipmentreportable segment | revenue intersegment | 2025-07-01 → 2025-12-31 | ¥900m |
| Medical Equipmentreportable segment | segment profit | 2025-07-01 → 2025-12-31 | ¥555m |
| SPDreportable segment | revenue | 2025-07-01 → 2025-12-31 | ¥3.0bn |
| SPDreportable segment | revenue external | 2025-07-01 → 2025-12-31 | ¥3.0bn |
| SPDreportable segment | revenue intersegment | 2025-07-01 → 2025-12-31 | ¥66m |
| SPDreportable segment | segment profit | 2025-07-01 → 2025-12-31 | ¥64m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-07-01 → 2025-12-31 | ¥63.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-07-01 → 2025-12-31 | ¥62.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-07-01 → 2025-12-31 | ¥966m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-07-01 → 2025-12-31 | ¥742m |
| Reconciling Itemsreconciling | revenue | 2024-07-01 → 2024-12-31 | −¥880m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-07-01 → 2024-12-31 | −¥880m |
| Reconciling Itemsreconciling | segment profit | 2024-07-01 → 2024-12-31 | −¥67m |
| Care Nursing Goodsreportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥1.4bn |
| Care Nursing Goodsreportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥1.4bn |
| Care Nursing Goodsreportable segment | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥19,000 |
| Care Nursing Goodsreportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥105m |
| Medical Equipmentreportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥57.3bn |
| Medical Equipmentreportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥56.5bn |
| Medical Equipmentreportable segment | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥816m |
| Medical Equipmentreportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥715m |
| SPDreportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥2.8bn |
| SPDreportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥2.8bn |
| SPDreportable segment | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥64m |
| SPDreportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥55m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-07-01 → 2024-12-31 | ¥61.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-07-01 → 2024-12-31 | ¥60.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥880m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-07-01 → 2024-12-31 | ¥875m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 534
| Item | Context | Value | Unit |
|---|---|---|---|
| Increase in cash and cash equivalents from newly consolidated subsidiary cce | Prior1InterimDuration | 60661000 | JPY |
| Increase in cash and cash equivalents from newly consolidated subsidiary cce | InterimDuration | － | JPY |
| Cash and cash equivalents | Prior1InterimInstant | 2593270000 | JPY |
| Cash and cash equivalents | InterimInstant | 2856109000 | JPY |
| Allowance for doubtful accounts notes trade receivables and contract asset | Prior1YearInstant | 12710000 | JPY |
| Allowance for doubtful accounts notes trade receivables and contract asset | InterimInstant | 13612000 | JPY |
| Allowance for doubtful accounts electronically recorded monetary claims operating ca by group | Prior1YearInstant | 1770000 | JPY |
| Allowance for doubtful accounts electronically recorded monetary claims operating ca by group | InterimInstant | 2099000 | JPY |
| Allowance for doubtful accounts ioa by group | Prior1YearInstant | 16974000 | JPY |
| Allowance for doubtful accounts ioa by group | InterimInstant | 23346000 | JPY |
| Payroll and allowances sga | Prior1InterimDuration | 2710743000 | JPY |
| Payroll and allowances sga | InterimDuration | 2778132000 | JPY |
| Provision for bonuses sga | Prior1InterimDuration | 33861000 | JPY |
| Provision for bonuses sga | InterimDuration | 37036000 | JPY |
| Provision for directors bonuses sga | Prior1InterimDuration | 8579000 | JPY |
| Provision for directors bonuses sga | InterimDuration | 11622000 | JPY |
| Retirement benefit expenses sga | Prior1InterimDuration | 120557000 | JPY |
| Retirement benefit expenses sga | InterimDuration | 125766000 | JPY |
| Provision for directors retirement benefits sga | Prior1InterimDuration | 1226000 | JPY |
| Provision for directors retirement benefits sga | InterimDuration | 2800000 | JPY |
| Provision for share based remuneration for directors and other officers sga | Prior1InterimDuration | 24167000 | JPY |
| Provision for share based remuneration for directors and other officers sga | InterimDuration | 23163000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1InterimDuration | -1122000 | JPY |
| Provision of allowance for doubtful accounts sga | InterimDuration | 8559000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E02928-000MedicalEquipmentReportableSegmentsMember | 56478883000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E02928-000SPDReportableSegmentsMember | 2778871000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E02928-000CareNursingGoodsReportableSegmentsMember | 1369939000 | JPY |
| Revenues from external customers | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 60627694000 | JPY |
| Revenues from external customers | Prior1InterimDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1InterimDuration | 60627694000 | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E02928-000MedicalEquipmentReportableSegmentsMember | 815786000 | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E02928-000SPDReportableSegmentsMember | 63887000 | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E02928-000CareNursingGoodsReportableSegmentsMember | 19000 | JPY |
| Transactions with other segments | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 879694000 | JPY |
| Transactions with other segments | Prior1InterimDuration_ReconcilingItemsMember | -879694000 | JPY |
| Transactions with other segments | Prior1InterimDuration | － | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E02928-000MedicalEquipmentReportableSegmentsMember | 57294669000 | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E02928-000SPDReportableSegmentsMember | 2842759000 | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E02928-000CareNursingGoodsReportableSegmentsMember | 1369959000 | JPY |
| Net sales | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 61507388000 | JPY |
| Net sales | Prior1InterimDuration_ReconcilingItemsMember | -879694000 | JPY |
| Net sales | Prior1InterimDuration | 60627694000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E02928-000MedicalEquipmentReportableSegmentsMember | 715007000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E02928-000SPDReportableSegmentsMember | 55041000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E02928-000CareNursingGoodsReportableSegmentsMember | 105326000 | JPY |
| Operating income | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 875375000 | JPY |
| Operating income | Prior1InterimDuration_ReconcilingItemsMember | -67254000 | JPY |
| Operating income | Prior1InterimDuration | 808120000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E02928-000MedicalEquipmentReportableSegmentsMember | 58022351000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E02928-000SPDReportableSegmentsMember | 2962161000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |